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Insights into the biochemical mechanism of maleic acid-induced Fan-
coni syndrome. Maleic acid administration is known to produce the
Fanconi syndrome, although the biochemical mechanism is incompletely
understood. In this study the effect of a single injection of maleic acid (50
mg/kg body wt, iv.) on the rat renal ATPases was examined. Maleic acid
rapidly caused bicarbonaturia, natriuresis, and kaliuresis. When nephron
segments were microdissected, there was an 81 2% reduction in
proximal convoluted tubule (PCT) Na-K-ATPase activity (P < 0.005) and
a 48 4% reduction in PCT H-ATPase activity (P < 0.01). Enzyme
activity (Na-K-ATPase, H-ATPase, H-K-ATPase) in the medullary thick
ascending limb of Henle's loop and distal nephron segments was normal.
In vitro, maleic acid (1 and 10 mM) inhibited Na-K-ATPase in PCT, but it
had no effect on H-ATPase in PCT. Prior phosphate infusion to maleic
acid-treated rats attenuated urinary bicarbonate wastage by 50% (P <
0.05); activity of proximal tubule Na-K-ATPase and H-ATPase activities
were partially protected as compared to the animals given maleic acid
alone (P < 0.05). Renal cortical ATP levels were not altered at the
concentration of maleic acid used in this study (that is, 50 mg/kg body wt),
but higher doses of maleic acid (that is, 500 and 1000 mg/kg body wt)
caused ATP levels to fall. Maleic acid did not affect cortical medullary
total phosphate concentration, however, P32 turnover (1 and 24 hr) was
altered by prior phosphate infusion. A protective effect of prior phosphate
loading on the membrane bound Pi pooi (insoluble) was seen while the
cytosolic Pi pool (soluble) was not different from control. Thus, maleic
acid-induced "Fanconi" syndrome likely results from both direct inhibition
of proximal tubule Na-K-ATPase activity and membrane-bound phospho-
rus depletion. The former mechanism would reduce activity of the
sodium-dependent transporters (that is, Na/H antiporter), while the latter
would inhibit the electrogenic proton pump (H-ATPase). The combina-
tion of reduced proximal tubule Na-H exchange and H-ATPase activities
would markedly inhibit bicarbonate reabsorption and result in the meta-
bolic acidosis universally seen in the Fanconi syndrome.
Maleic acid is known to cause a disorder to tubular reabsorp-
tion resembling the Fanconi syndrome [1—5]. Most previous
studies have shown that the proximal tubule is the sole affected
nephron segment [3—7], although a recent work suggests that the
distal tubule might also be involved [8]. Solute transport in
proximal tubule is mainly linked to sodium, and thus, depends on
activity of the basolateral Na-K-ATPase [9, 101. Bicarbonate
reabsorption occurs primarily via the brush border Na/H anti-
porter and to a lesser degree by an electrogenic sodium-indepen-
dent H-ATPase pump [10, 11].
A defect in the proximal tubule Na-K-ATPase appears to be the
most reasonable proximate cause of maleic acid-induced Fanconi
syndrome [7, 10, 12]. Studies in renal homogenates show that
maleic acid (1000 mg/kg body wt) inhibits Na-K-ATPase activity
and reduces ATP concentration in the cortex, but not in the
medulla [13, 14]. Mujais [15] recently demonstrated an inhibitory
effect of maleic acid only on proximal convoluted tubule (PCT)
Na-K-ATPase. The effect of maleic acid on H-ATPase activity and
H-K-ATPase activities in microdissected nephron fragments has
not been studied. Both of these enzymes are important in urinary
acidification, the former in the proximal and distal nephron and
the latter in the collecting duct.
Al-Bander et al [16] showed that prior phosphate infusion to
dog attenuated the bicarbonaturia induced by maleic acid, sug-
gesting that intracellular phosphorus depletion is a main feature
of this disorder. Proof of this, however, has not yet been offered.
Whether the beneficial effect of prior phosphate treatment is
associated with the enhancement of renal ATPase activities is also
unknown.
We studied the effects of a single dose of maleic acid on the
three renal ATPases in individual microdissected nephron seg-
ments. Renal phosphorus concentration, P32 turnover and ATP
levels following maleic acid treatment were also measured. We
further examined the effect of prior phosphate infusion on these
parameters in the maleic acid-induced model of the Fanconi
syndrome. Our results suggest that in this model, Na-K-ATPase
and H-ATPase inhibition in the proximal tubule is the most likely
mechanism for the subsequent development of metabolic acidosis.
While phosphate infusion is protective, the mechanism is via a
salutory effect on the membrane bound P32 pool, not by affecting
tissue ATP levels.
Methods
All experiments were performed in male Sprague-Dawley rats
weighing 150 to 200 g. The animals had free access to the usual
laboratory diet and were given tap water to drink ad libitum.
In vivo studies
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Animal preparation. Animals were anesthetized with sodium
pentobarbital and Ketamine® A thin polyethylene catheter was
placed in the femoral vein for continuous infusion of Ringer-
mannitol solution; another catheter was inserted in the femoral
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artery for blood samples. The Ringer-mannitol solution contained
(in mEq/liter): Na 140, K 4, HCO3 24,Cl 120, and mannitol 5%.
The bladder was cannulated for urine collection; each period was
15 minutes. Blood samples (0.1 ml) were obtained at the midpoint
of each urine collection. The infusion rate was adjusted to urine
flow rate plus insensible losses, and it varied in the four experi-
mental groups. One to two hours was allowed for equilibration
before the beginning of clearance collections [171.
The animals were divided into the following four groups (N =
6 per group):
Group 1. Control (C) animals received only the Ringer-manni-
tol infusion.
Group 2. Maleic acid (MA) was intravenously administered into
each rat as a single dose of 50 mg/kg body wt over five minutes.
The acid was dissolved in 0.9% NaC1 and the pH of the solution
adjusted to 7.4 by addition of 1 N NaOH. Previous work has shown
this to be the smallest effective dose not substantially altering
renal hemodynamics [18].
In preliminary studies we showed that maleic acid induced its
effects (that is, diuresis and bicarbonaturia) immediately after
drug administration. The greatest urinary bicarbonate wastage
was observed at 45 minutes following administration of the agent;
while the effect persisted for hours, it gradually decreased in
magnitude. Consequently, all of the metabolic data and renal
ATPase activities reported in the present study were the results of
observations made 45 minutes after maleic acid administration.
Group 3. Phosphate infusion plus maleic acid (PU4 + MA). A
solution of neutral sodium phosphate (pH 7.40, Na 161 mEq/liter,
phosphorus 2.8 mg/mI) was infused for 60 minutes before maleic
acid administration and was continuously given for the remainder
of the experiment (45 mm).
Group 4. Phosphate infusion (P04). The animals in this group
were treated solely with the neutral sodium phosphate infusion in
a similar fashion to Group 3.
Tubule microdissection and enzymatic measurements
Renal tubules were microdissected as previously described [19].
In brief, the left renal artery was cannulated and the kidney was
perfused for 15 minutes in situ at a rate of 0.7 ml/min with a
balanced salt solution containing 400 U/mI collagenase, 4°C, pH
7.4. The kidneys were then cut along the cortico-papillary axis and
incubated in 3 ml of collagenase-albumin containing Hank's
solution at 35°C for 12 minutes. The tissues were continuously
bubbled with compressed air (3 psi). After incubation, the pyra-
mids were rinsed and immediately microdissected. The tubule
segments were identified as proximal convoluted tubule (PCT),
medullary thick ascending limb of Henle's loop (MTAL), cortical
collecting tubule (CCT), and medullary collecting tubule (MCT).
To remove most of the extracellular potassium, nephron seg-
ments were incubated for 15 minutes at 37°C (pH 7.4) in
potassium-free buffer. The nephron segments were then subjected
to a two-step hypotonic-hypothermic shock and ATPase activities
were determined using y32 P-labeled ATP (37°C, 15 mm, pH 7.4).
H-ATPase, H-K-ATPase, and Na-K-ATPase were measured by
the radiochemical method of Doucet and Marcy [20] as subse-
quently described by us [211.
In vitro studies
To further examine the direct effect of maleic acid on Na-K-
ATPase and H-ATPase activities in the proximal tubule, in vitro
studies were performed as previously described [22]. In brief,
segments of PCT were first microdissected from normal animals.
After the hypotonic-hypothermic shock, tubule segments were
pre-incubated for 45 minutes in vitro in 1.2 tl of buffer without
ATP, but with varying doses of maleic acid (1 or 10 mM). After
pre-incubation, the solution was replaced with one appropriate
for the enzyme analysis to be performed.
Enzyme activity is expressed as pmol/mm tubule length/hr of
ATP hydrolyzed. All samples were run in triplicate or quadrupli-
cate, and appropriate corrections were made for blanks and the
spontaneous hydrolysis of ATP.
Determination of tissue phosphorus concentration and
P32 turnover
To determine the precise effect of maleic acid on renal tissue Pi
concentration, cortex and medulla were separated and processed
separately in an additional set of animals. Appropriate corrections
were made for background and color quenching and all samples
were run in triplicate. Tissue samples were placed in a Potter-
Elvehjem homogenizer in buffer containing 0.25 M sucrose, 2 ms'i
MgCl2, 1 mM EGTA in 2 mM Tris-HCI pH 7.4, 4°C (5.5 mI/cortex;
1.5 ml/medulla). Samples of homogenates (0.1 ml) were mixed
with 0.1 ml of 20% trichloroacetic acid and allowed to stand at 0
to 4°C for at least 30 minutes. The resulting precipitate was
centrifuged (1500 g, 15 mm, 4°C) and Pi and P32 analyzed in both
the supernate (soluble pool) and the residue (insoluble pool). The
residue was digested 0.5 N NaOH. Aliquots (0.25 ml) were
removed and digested with 0,1 ml 60% perchloric acid at 200 to
300°C until clear, diluted with water to a volume of 1 ml, and used
for the determination of Pi [23]. This method measures insoluble
tissue phosphate. Protein concentration was measured by the
method of Lowry et al [24].
High specific activity P32 (4 tCi/kg) was injected into a separate
group of six animals. After 1 or 24 hours the animals were given
maleic acid or MA plus phosphate. At the end of 45 minutes, the
animals were sacrificed and P32 metabolism and phosphorus
concentration in cortex (soluble and insoluble pools) was mea-
sured.
Determination of tissue A TP concentration
Additional experiments were performed to determine ATP
concentration in cortex and medulla. In brief, 200 mg of freshly
dissected samples of cortex and medulla from animals in each
experimental group were homogenized in 3.5 ml buffer at 4°C
containing magnesium, DTT, EDTA, bovine serum albumin and
tricine buffer salts (Stock #FL-ASC, FL-AAB; Sigma Chemical
Company, St. Louis, MO, USA). Aliquots (3 ml) were then
centrifuged for 15 minutes at 140,000 g. ATP assay mix (FL-
AAM) (0.1 ml) was added to the reaction vial for three minutes at
21°C. In a separate test tube containing 0.1 ml of the somatic cell
releasing reagent (FL-SAR), an aliquot of the cell homogenate
was added, mixed and transferred to the reaction vial. ATP
concentration in the supernate was determined using the luciferin/
luciferase reaction with the aid of a light R2010 Analytical
Luminescent Laboratory luminometer. Internal standards were
routinely run by adding 0.1 ml of the ATP assay mix to a reaction
vial, and after three minutes adding 0.1 ml somatic cell ATP
releasing agent and 0.05 ml of an appropriate ATP standard. One
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Table 1. Effect of maleic acid and prior phosphate infusion on metabolic parameters and renal function
Parameters C MA P04 P04 + MA
Plasma Pi mmol/liter 2.45 0.22 2.28 0.31 6.67 0.411 6.46 0.75"
Plasma HCO3 mEqiliter 24 1 22 2 22 2 23 2
Urine pH
UrineP02mmHg
C ml/min/100 g body wt
6.62 0.08
42±3
0.86 0.04
7.46 0.04"
92±4"
0.80 0.06
6.54 0.07
48±3
0.88 0.05
7.02 0O6
75±2a,C
0.81 0.04
V/Ccr % 4.91 0.24 10.62 0.41" 5.43 0.31 7.49 Ø37a.c
FEHC03 %
FENa %
FEK %
0.60 0.07
0.94 0.0833 2
6.42 0.09"
7.65 0.66"
102 4"
0.71 0.10
7.14 052b
35 3
3.41 0.04
9.26 057b,c
81
FEE, % 1.27 0.10 1.12 0.08 0.71 0.04a 1.31 0.11
FE1 % 14.6 0.90 46.4 2.2" 104.6 22" 118.5
Abbreviations are: Ce,. creatinine clearance; V/Ce,, fractional volume excretion, FEHc0,, fractional bicarbonate excretion; FEN, fractional sodium
excretion; FEK, fractional potassium excretion; FE1, fractional chloride excretion; FEE,, fractional phosphate excretion. N = 6 in each group.
"P < 0.01
hp < 0.01 vs. C
"P < 0.05 vs. MA
dP < 0.01 vs. C and MA
tenth ml was transferred to the reaction vial and light emission
was measured immediately.
The amount of ATP (per mg protein) in the cell supernate was
calculated using the equation:
—
ATP0S) X '-SAM)ATP(s) -
1-(SAM + Is) — '-(SAM)
where ATP(SAM) is the ATP in the cell sample (in moles); ATP(IS)
is the ATP of the added internal standard (in moles); L(SAM) is
the light emitted by the cell sample; and L(SAM±,s) is the light
emitted by the cell sample plus the internal standard.
In additional experiments, control animals were infused with
two higher concentrations of maleic acid for 45 minutes (500 and
1000 mg/kg body wt). Samples of cortex and medulla were
removed and ATP concentrations were measured as described
above. The higher concentrations were chosen to verify results
published in the literature known to decrease cell ATP and were
then compared to results in our study (50 mg/kg body wt).
Materials
All chemicals and reagents were obtained from Sigma Chemical
Co. and were of highest purity. Radiolabeled ATP was obtained
from New England Nuclear (Boston, MA, USA).
Statistics
Statistical significance was assessed using Student's t-test or
analysis of covariance, where appropriate, with P values of 0.05 or
less being significant.
Results
Effects of maleic acid and prior phosphate infusion on metabolic
parameters and renal function
There were no significant differences in blood values (Na, K, Cl,
glucose, creatinine) among the animal groups except for plasma
phosphate (Table 1). In P04 and P04 + MA groups, plasma
phosphate concentration was about three times that of the control
and MA groups (6.46 0.75 vs. 2.28 0.31 mmol/liter, P04 +
MA vs. MA; N = 12, P < 0.01). There was no significant
difference in renal function (as assessed by creatinine clearance)
however, maleic acid administration (MA group) induced a
marked diuresis (V/Car = 10.62 0.41 vs. 4.91 0.24%; FENa
7.65 0.66 vs. 0.94 0.08%), increased urine pH (7.46 0.04 vs.
6.62 0.08) and urine pCO2 (92 4 vs. 42 3 mm Hg), and was
associated with enhanced urinary excretion of bicarbonate, potas-
sium, and phosphate (P < 0.01 vs. control). There was no
significant change in FEE, between the MA and the control
groups. Phosphate loading alone (P04) caused increased FENa
and FE,4 (P < 0.01) as compared to control, but it decreased
FE1 (P < 0.05 vs. control). During the one hour and 45 minute
time period this group received 13.82 mg phosphate/kg body wt.
In the P04+MA group, it is obvious that prior phosphate
infusion attenuated maleic acid-induced alterations (MA group)
in urinary excretion of electrolytes. V/Car, FEHCO,, FEK, and pH
values were significantly lower than those of the MA group (P <
0.05), however, phosphate infusion could not totally prevent the
defects caused by maleic acid. During the one hour and 45 minute
time period this group received 15.30 mg phosphate/kg body wt.
In vivo effects of maleic acid on renal ATPase enzymes
Na-K-ATPase activity in maleic acid treated rats (Fig. 1) was
markedly decreased in PCT (by 81 1.6%) as compared to
control (P < 0.05). Maleic acid had no effect on Na-K-ATPase
activity in MTAL, CCT, and MCT. H-ATPase activity in MA
animals (Fig. 2) was decreased by 48 3% in PCT (P < 0.01)
while enzyme activity was unchanged in the other nephron
segments examined. H-K-ATPase activity in the collecting tubule
(CCT and MCT) was not altered by maleic acid injection (Fig. 3).
In vitro effects of maleic acid on renal A TPase enzymes
In vitro maleic acid had a direct inhibitory effect Na-K-ATPase
activity in a PCT (Table 2). Enzyme activity was decreased by 35
1.8% (P < 0.05) at 1 m and 53 1.0% (P < 0.01) at 10 mM
maleic acid. PCT and CCT H-ATPase activities were not affected
by maleic acid. Varying concentrations of phosphate in the buffer
(0.1 to 10 mM) had no effect on PCT Na-K-ATPase or H-ATPase
activity in PCT (data not shown).
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Effect of maleic acid prior phosphate infusion on renal
A TPase enzymes
As shown above and replotted, H-ATPase activity (Fig. 4) in
animals receiving MA phosphate was significantly lower than
control (P < 0.01); prior phosphate infusion significantly in-
creased enzyme activity towards normal, but despite the phos-
phate load enzyme activity was less than control. Similar results
were found for Na-K-ATPase in the proximal tubule (Fig. 4),
although the percentage improvement with phosphate infusion
was substantial. Phosphate infusion to MA-treated animals tripled
Na-K-ATPase activity (P < 0.05 vs. MA).
Effect of maleic acid and prior phosphate infusion on renal
Pi concentration
Maleic acid had no significant effect on tissue Pi concentration,
in either cortex or medulla. Phosphate infusion was also without
effect (data not shown).
To further examine this, additional studies using P32 were
performed. In these experiments radiolabeled P32 was injected
into the animals, and 1 or 24 hours later tissue Pi pools in the
cortex were analyzed (Table 3). The results (at 1 hr) showed that
maleic acid decreased only the insoluble Pi pooi (protein-bound
Pi) and that prior phosphate infusion protected both the soluble
(cytosolic) and the insoluble (or protein bound) newly synthesized
300
100
0
C MA P04 P04 C MA P04 P04
+MA +MA
PCT H-ATPase PCT Na-K-ATPase
Fig. 4. Effect of prior phosphate infusion on PCT H-ATPase and PCT
Na-K-A TPase activities in maleic acid-treated rat; N = 6 in each group; *P
< 0.005; P < 0.01; #P < 0.05 versus C or P04; §P < 0.05 versus MA.
protein poois. With phosphate loading, the soluble Pi pool
increased by approximately 33% to 50% and the insoluble pool
increased by approximately 75% as compared to control or maleic
acid-infused animals. Similar results were obtained for the 24-
hour time period (data not shown).
L
5,000
4,000
: 3,0000
2,000
0
1,000
PCT MTAL CCT MCT
Fig. 1. In vivo effect of maleic acid on Na-K-A TPase activity in PCT,
MTAL, CCT, MCT; N = 6 in each group; *JL' < 0.01 versus control animals.
Symbols are: () C; (U) MA.
500
400
300
200
a. 100
I 0
PCT MTAL CCT MCT
Fig. 2. In vivo effect of maleic acid on H-A TPase activity in PCT, MTAL,
CCT, MCT; N = 6 in each group; *P < 0.01 versus control animals. Symbols
are: () C; (U) MA
200
Fig. 3. In vivo effect of maleic acid on H-K-A TPase activity in CCT and
MCT; N = 6 ineach group. Symbols are: () C; (U) MA. The activities of
H-K-ATPase in PCT and MTAL are not shown as the values are veiy low
(< 10 pmol/mm/hr in both segments).
Table 2. In vitro effect of maleic acid on PCT and CCT transport
enzymes
Group
Na-K-ATPase H-ATPase
PCT CCTPCT CCT
Control 2312 80 905 26 417 14 270 14
MA 1 m
10 mM
1499 85
1097 45k'
893 15
904 24
411 13
401 17
280 20
276 15
Values are means SE and expressed as pmol/mm/hr; N = 6 in each
group. Abbreviations are: PCT, proximal convoluted tubule; CCT, cortical
collecting tubule.
ap < 0.05, 'P < 0.01 vs. control
100
80
60
o 400
20
0
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Table 3. Effect of phosphate and maleic acid on P32 soluble (cytosolic)
and insoluble (membrane bound) pools in rat cortex
Group
Soluble phos
pool
phate Insoluble phosphate
pool
% of Control
Control 1.00 1.00
Maleic acid 1.08 0.74a
Phosphate infusion 1.33a 1.00
Maleic acid plus phosphate 1.48a 1.75a
a P < 0.001 from Control (N = 3 to 6 per group); P32 turnover at 1 hr
Table 4. Effect of maleic acid (50 mg/kg i.v.) on tissue ATP
concentration
Group
Cortex Medulla
% of Control
Control 1.00 1.00
Maleic acid 0.89 0.62a
Phosphate 1.01 0.99
Maleic acid plus phosphate 0.86 lila
a P < 0.05 (N = 6/group)
Effect of maleic acid and prior phosphate infusion on A TP
concentration in cortex and medulla
Infusion of 50 mg/kg maleic acid had a tendency to decrease
ATP concentration in renal cortex (Table 4), however, because of
the wide variability this decrease was not significant at the P <
0.05 level. In controls, cortical ATP was 1439 442 pg/mg
protein, and after maleic acid it was 1194 213 pg/mg protein
(NS, N = 12). Phosphate loading did not affect tissue ATP (1427
301 pg/mg protein) with or without maleic acid (1352 289
pg/mg protein, NS, N = 12). In the medulla, however, maleic acid
infusion decreased tissue ATP concentration by approximately
one-third (P < 0.05), and in this instance, the infusion of
phosphate was protective. Tissue ATP in control medulla was
6392 1261 pg/mg protein. After maleic acid it was 3334 1021
pg/mg protein (P < 0.05) and with MA + P04 it was 9630 1718
pg/mg protein (P < 0.05).
Because we did not observe a significant change in cortical ATP
levels after maleic acid, we performed additional experiments with
two higher concentrations, known to decrease tissue ATP levels
(that is, 500 to 1000 mg/kg body wt). We also repeated experi-
ments with 50 mg/kg to accumulate a total N of 10 per group
(Table 5). The two higher concentrations of maleic acid signifi-
cantly decreased tissue ATP, while the lowest dose was without
effect.
Discussion
The proximal tubule plays a major role in water and solute
reabsorption in the kidney [9, 10]. Most solute transport, including
bicarbonate, phosphate, amino acids, and glucose, is mediated by
Na-coupled mechanisms. Bicarbonate reabsorption in proximal
tubule is mediated in the main by the Na/H antiporter and to a
lesser degree by an electrogenic H-ATPase pump which is sodium
independent [9—11, 19]. The effectiveness of Na-dependent trans-
port depends on the maintenance of a low intracellular sodium
concentration, and the basolateral Na-K-ATPase plays the major
role in maintaining this process. The failure of proximal sodium
Table 5. Effect of maleic acid infusion on renal cortical ATP
Dose, i.v.
mg/kg/body wt
Cortex
% of Control
0 1.00
50 0.88
500 0.35a
1000 0.2P
a P < 0.001 (N = 10/group)
transport leads to a global failure in reabsorption known as the
Fanconi syndrome. Besides defective Na-K-ATPase activity, an
abnormality in membrane permeability, a decrease in ATP gen-
eration, and impaired membrane recycling or vacuolar trafficking
can cause a low cell sodium which could also cause the Fanconi
syndrome [10].
Administration of maleic acid, the cis-isomer of fumaric acid,
induces a diuresis associated with bicarbonaturia, glycosuria,
aminoaciduria, and phosphaturia. Most studies show that the
proximal tubule is the sole affected target organ of maleic acid
[3—5], although a recent study has suggested that distal nephron
might also be involved in the syndrome [8]. The underlying
mechanisms of maleic acid-induced Fanconi syndrome are still
unknown. Earlier studies in renal homogenates, prepared after
maleic acid treatment, showed that Na-K-ATPase activity was
markedly decreased in cortex while enzyme activity in medulla
was unchanged [13]. A recent study also showed that maleic acid
depressed Na-K-ATPase activity in the proximal convoluted tu-
bule but not in other segments [15]. H-ATPase in proximal tubule
and H-ATPase and H-K-ATPase in collecting tubule have not
been studied in maleic acid-treated animals. Whether a distal
acidification defect occurs following maleic acid treatment or not
is unexplored. Thus, the exact site of affected nephron segments
and the precise alterations in acidification-related renal ATPases
caused by maleic acid treatment are unclear.
Besides a possible direct inhibitory effect of maleic acid on
Na-K-ATPase activity, the acid is reported to decrease ATP
concentrations in renal cortical homogenates [13]. Maleic acid is
a potent inhibitor of the Krebs tricarboxylic acid cycle. Some
investigators contend that the decreased ATP caused by maleic
acid plays a central pathogenic role in the Fanconi syndrome [7,
13, 25]. This contention, however has been challenged by the
results of several studies. First, other tricarboxylic acid cycle
inhibitors, such as arsenite [3], malonate [26], and fluorocitrate
[27] do not cause the Fanconi syndrome. Second, pretreatment
with acetoacetate can abolish the bicarbonaturia, but it does not
improve the reduced ATP content observed following maleic acid
treatment [28]. Acetoacetate is a physiological substrate for
succinyl-CoA transferase and can compete with maleic acid to
prevent the formation of maleyl-CoA, resulting in CoA depletion
[29—31]. Furthermore, prior phosphate loading in dogs has been
shown to markedly ameliorate maleic acid-induced bicarbonatu-
na, natriuresis, and aminoaciduria, suggesting that maleic acid
limits the availability of intracellular phosphorus (sequestration or
depletion) [16].
A defect in the phosphorylation potential of the cell, that is,
changing the ATP/ADP-Pi, ratio, rather than decreased ATP
concentration, might be the proximate cause in the tubular
dysfunction caused by maleic acid. Measured total ATP content,
however, may not represent the real level of ATP at the site of the
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cell where transport takes place. At present, however, there are no
data available regarding to the renal phosphate concentrations
following maleic acid treatment. Whether improvement in renal
tubular function with phosphate infusion is related to the im-
provement in renal ATPase activity also remains unexplored.
The present study was conducted to examine the effect of
maleic acid and prior phosphate infusion on renal ATPases in
maleic acid-induced Fanconi syndrome. The results of our in vivo
study show that maleic acid has a selective inhibitory effect on
renal ATPases in the proximal tubule. Na-K-ATPase activity and
H-ATPase activity in PCT were decreased by about 80% and
50%, respectively. Maleic acid had no significant effect on renal
ATPase activities in medullary thick ascending limb of Henle's
loop or in collecting tubule. Our in vitro studies clearly show that
maleic acid directly inhibits Na-K-ATPase activity in PCT while
H-ATPase activity was unaffected. While maleic acid-treated
animals showed no abnormality in tissue Pi concentration, turn-
over of P32 in the insoluble fraction (that is, membrane bound Pi)
was clearly decreased.
The selectively inhibitory effect of maleic acid on proximal
tubule Na-K-ATPase activity found in the current study agrees
with that reported by Mujais [15]. His study, however, did not
examine the effect of maleic acid on proximal tubule H-ATPase or
on collecting tubule H-ATPase and H-K-ATPase activity. We also
examined the direct effect of maleic acid on proximal tubule
Na-K-ATPase activity in vitro (Table 2). Our data clearly indicate
that the biochemical defects induced by maleic acid are confined
solely in the proximal tubule. The decreased Na-K-ATPase activ-
ity likely causes the failure of Na-dependent transport. The
urinary bicarbonate wastage following maleic acid treatment is
probably caused by a combination of defects in both the Na/H
antiporter and H-ATPase of the proximal tubule. The mechanism
for the selective effect of maleic acid on proximal tubule Na-K-
ATPase is not known, but it suggests that isoforms of the enzyme
may be different from distal segments.
The location of the bicarbonate defect observed in the present
study is in agreement previous clearance studies demonstrating
that the site primarily affected by maleic acid-induced bicarbona-
tuna is the proximal tubule [3—8]. Morphological studies also
indicate that the lesions are confined to the proximal tubule and
the extent of abnormal changes are dose dependent [5, 32—34].
Structural changes in mitochondria were observed when the dose
of maleic acid treatment was high. While the distal tubules
appeared normal, the collecting tubules in the outer medulla
showed an increased number of dark cells (per total cell popula-
tion). These results were considered to represent an adaptive
response to the functional abnormalities, in particular to the
osmotic diuresis and hypokalemia, rather than to a specific cell
injury. The data in our study also indicate that renal ATPase
activities in distal nephron segments are unaltered by maleic acid
treatment.
Our study in rats confirms that prior phosphate infusion to dogs
could attenuate bicarbonaturia induced by maleic acid [16]. We
further demonstrated that the improvement in urinary bicarbon-
ate wastage was accompanied both by increased renal cortical P32
turnover (membrane bound) and by improvement in PCT Na-K-
ATPase and H-ATPase activities, both of which are membrane
bound enzymes (Table 3). These findings point to a role of
membrane-bound phosphorus depletion in the pathogenesis of
maleic acid-induced bicarbonaturia. Guntupalli et al [18] recently
showed that maleic acid-induced phosphaturia is expressed at the
apical membrane entry step of inorganic phosphorus.
Inorganic phosphorus concentration in the cytosol (that is,
soluble Pi) is thought to mainly represent intracellular ATP
concentration. That total tissue Pi concentration (soluble) did not
change following maleic acid treatment, suggests that the ATP
levels in proximal tubule are normal (or near normal; Table 3).
Indeed, direct measurement of cortical ATP following maleic acid
(50 mg/kg) were similar to control. These data suggest that ATP
is not rate limiting in this model of the Fanconi syndrome, at least
not at concentrations causing bicarbonaturia, phosphaturia and a
fall in enzyme activity (Table 4). While higher concentrations of
maleic acid were associated with a fall in ATP, it is clearly not part
of the pathogenesis in this model of the Fanconi syndrome, rather
it is an epiphenomenon (Table 5).
Maleic acid increases the renal excretion of small molecular
weight proteins and lysosomal enzymes [14, 35, 36]. Ultrastruc-
tural studies show this to reflect an abnormality of endocytosis/
exocytosis and membrane recycling in the proximal tubule [371.
The exocytosis of both the electrogenic H-ATPase and endosomal
electroneutral Na/H antiporters might also be impaired following
maleic acid treatment. Prior phosphate infusion can attenuate the
urinary wastage of some small molecular weight proteins [35].
These observations, combined with ours showing improved P32
turnover (membrane bound) suggest the exocytosis/endocytosis
defect following maleic acid treatment might be improved by prior
phosphate infusion.
Proton secretion by I—I-ATPase in the proximal tubule does not
depend on the existence of low intracellular sodium or on
Na-K-ATPase function [11]. The present study clearly shows that
maleic acid has no direct inhibitory effect on H-ATPase activity
(Table 2); thus, the mechanisms of the decreased H-ATPase
activity observed in in vivo are still to be determined. It may be
that maleic acid induces its abnormality by altering the integrity of
the membrane bound enzyme. In concurrence with this hypothe-
sis, we show that prior phosphate infusion improved H-ATPase
activity in PCT.
The defects in proximal tubular Na-dependent transport in-
duced by maleic acid are generally considered as the result of
energy failure from the defect in the Na-K-ATPase. Prior exper-
iments of the effect of maleic acid on Na-dependent glucose and
Na-dependent amino acid in brush-border membrane vesicles or
kidney cortex slices, however, have yielded conflicting results,
reporting either inhibition or no effect [38—40]. The Na/H anti-
porter might be disturbed by either a direct effect of maleic acid
or secondarily by a defect in Na-K-ATPase. At present, however,
there are no data as regards activity or kinetic characteristics of
the Na/H antiporter following maleic acid treatment. Finally, our
studies show that maleic acid had no effect on MTAL or MCT
segments (ATPase activities), yet the agent markedly decreased
medullary ATP content (which phosphate loading returned to
normal).
In conclusion, maleic acid administration markedly inhibits
Na-K-ATPase and H-ATPase activities in proximal tubule. Maleic
acid also depresses Na-K-ATPase in vitro (but not H-ATPase) and
causes cellular membrane-bound P32 depletion without affecting
tissue ATP levels. Defects in the Na/H antiporter caused primarily
by maleic acid or secondarily to decreased Na-K-ATPase activity
and the impairment of H-ATPase pump are likely the proximate
1548 Eiam-ong et al: Maleic acid and renal ATPases
biochemical causes of the resulting bicarbonaturia. Prior phos-
phate infusion can attenuate the urinary bicarbonate wastage; this
occurs in association with increased membrane-bound P32 turnover
and improved proximal Na-K-ATPase and H-ATPase activities.
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